Surmodics, Inc. (SRDX) Financials

SRDX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 180.2 million 58.1 million
2023-09-30 185.7 million 65.8 million
2023-06-30 188.9 million 76.5 million
2023-03-31 166.2 million 63.6 million

SRDX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -9.5 million 2.0 million
2023-09-30 502000 1.9 million
2023-06-30 25.4 million 1.9 million
2023-03-31 -6.5 million 1.8 million

SRDX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -786000
2023-09-30 6.7 million
2023-06-30 7.3 million
2023-03-31 -7.7 million

SRDX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 35.2 million - 4.4 million
2023-09-30 45.4 million - 3.8 million
2023-06-30 44.6 million 29.4 million 4.1 million
2023-03-31 19.2 million 29.3 million 4.4 million

SRDX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 14.1 million
2023-09-30 14.2 million
2023-06-30 14.1 million
2023-03-31 14.0 million

SRDX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 720000 2.5 million 12.5 million -
2023-09-30 748000 2.6 million 25.8 million 3000
2023-06-30 470000 2.7 million 12.9 million -
2023-03-31 723000 2.4 million 13.0 million 3000

SRDX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 30.6 million 17.5 million
2023-09-30 28.0 million 16.7 million
2023-06-30 52.5 million 18.2 million
2023-03-31 27.2 million 18.7 million

SRDX

Price: $26.17

52 week price:
16.79
39.41

Earnings Per Share: 0.39 USD

P/E Ratio: 79.85

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 34922

Ebitda: 887000

Market Capitalization: 390.9 million

Links: